IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CARPO, MARINELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.264
AS - Asia 7.290
NA - Nord America 7.228
SA - Sud America 967
AF - Africa 198
OC - Oceania 99
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.781
GB - Regno Unito 3.253
IT - Italia 2.054
CN - Cina 2.006
SG - Singapore 1.894
RU - Federazione Russa 875
DE - Germania 816
SE - Svezia 743
JP - Giappone 598
BR - Brasile 595
VN - Vietnam 555
FR - Francia 543
TR - Turchia 450
IN - India 424
HK - Hong Kong 423
KR - Corea 384
NL - Olanda 295
CA - Canada 287
IE - Irlanda 278
UA - Ucraina 253
FI - Finlandia 222
BD - Bangladesh 212
ES - Italia 205
PL - Polonia 162
EU - Europa 149
AR - Argentina 119
CO - Colombia 114
GR - Grecia 103
MX - Messico 98
AU - Australia 90
DK - Danimarca 88
BE - Belgio 79
ID - Indonesia 71
CH - Svizzera 66
CI - Costa d'Avorio 57
AT - Austria 50
CL - Cile 49
RO - Romania 44
PT - Portogallo 35
TH - Thailandia 31
IQ - Iraq 28
TW - Taiwan 28
ZA - Sudafrica 25
UY - Uruguay 24
LY - Libia 23
TN - Tunisia 22
PE - Perù 19
PK - Pakistan 19
EC - Ecuador 18
EG - Egitto 18
MA - Marocco 18
MY - Malesia 18
PH - Filippine 17
AE - Emirati Arabi Uniti 15
IR - Iran 15
VE - Venezuela 15
GT - Guatemala 13
SA - Arabia Saudita 13
SI - Slovenia 13
IL - Israele 12
CR - Costa Rica 11
HR - Croazia 11
LB - Libano 11
RS - Serbia 11
HU - Ungheria 9
OM - Oman 9
PY - Paraguay 9
UZ - Uzbekistan 9
DZ - Algeria 8
JM - Giamaica 8
JO - Giordania 8
KE - Kenya 8
LT - Lituania 8
NZ - Nuova Zelanda 8
NP - Nepal 7
SV - El Salvador 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
NO - Norvegia 6
PS - Palestinian Territory 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
BB - Barbados 4
BG - Bulgaria 4
IS - Islanda 4
LU - Lussemburgo 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GA - Gabon 3
HN - Honduras 3
MQ - Martinica 3
PR - Porto Rico 3
SN - Senegal 3
AM - Armenia 2
CU - Cuba 2
CY - Cipro 2
Totale 26.157
Salva come PNG Salva come JPEG
Città #
Southend 2.864
Singapore 1.045
Chandler 545
Seattle 519
Milan 457
Ashburn 429
San Jose 406
Hong Kong 395
Beijing 372
Princeton 365
Dublin 276
Wilmington 266
Redmond 197
Council Bluffs 196
Santa Clara 186
New York 184
Los Angeles 183
Tokyo 176
Redwood City 172
Rome 164
Toronto 152
Bengaluru 151
Ho Chi Minh City 149
Lauterbourg 148
Nanjing 147
Dallas 141
Sakarya 139
Moscow 132
Mountain View 131
Des Moines 128
Boardman 126
Jacksonville 117
Hanoi 109
Buffalo 101
Frankfurt am Main 97
Ann Arbor 96
Dearborn 90
Fairfield 81
Jinan 80
Warsaw 80
Guangzhou 79
Athens 77
Shenyang 73
Shanghai 71
São Paulo 71
Eitensheim 70
Houston 69
Woodbridge 68
Berlin 62
Paris 60
Abidjan 57
Hebei 56
Buenos Aires 55
Bogotá 53
London 51
Changsha 47
Istanbul 45
Serra 43
Munich 41
Tianjin 41
Brussels 40
Nanchang 38
Verona 38
Bitonto 37
Cangzhou 37
Madrid 37
Dong Ket 36
Hefei 36
Andover 35
Ottawa 35
Helsinki 34
Phoenix 34
San Diego 34
Santiago 34
Barcelona 32
Columbus 32
Naples 32
Chicago 31
Mumbai 31
Turin 31
Duncan 29
The Dalles 28
Zhengzhou 28
Nuremberg 27
Philadelphia 26
Vienna 26
Montreal 25
Prato 25
Florence 24
Jakarta 24
Boston 23
Fuzhou 23
Jiaxing 23
Grafing 22
Medellín 22
Osaka 22
Shenzhen 22
Sydney 22
Copenhagen 21
Hangzhou 21
Totale 14.158
Salva come PNG Salva come JPEG
Nome #
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 4.030
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 745
Impact of environmental factors and physical activity on disability and quality of life in CIDP 637
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 632
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 615
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 357
Rilevanza diagnostica degli anticorpi antinervo nelle neuropatie disimmuni 342
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 271
Caratterizzazione molecolare dei geni CLCN1, SCN4A, KCNJ2, CACNA1S in pazienti con canalopatie muscolari 248
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 247
High tumor necrosis factor-alpha levels in cerebrospinal fluid of cobalamin-deficient patients 246
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 243
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 215
Polymorphisms of the TNF-alphagene in italian GBS patients 214
Neuroborreliosis mimicking a paraneoplastic syndrome 207
Stiff-Person Syndrome responding to intrathecal baclofen. 207
Survival motor neuron (SMN1 and SMN2) genes copy number in multifocal motor neuropathy 205
Changes in neuroimmunological pattern in IVIg treated-MMN patients : a long term follow up 195
Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies 187
Role of TNF-alpha in modulating GBS phenotype in Italian patients 184
Long term disability and social status change after Guillain-Barré syndrome 180
A sporadic, atypical case of desminopathy: morphological and immunological characterization 180
How-long is IVIg effective in multifocal motor neuropathy? 179
Diagnostic relevance of anti-neural antibodies in dysimmune neuropathies 179
Molecular characterization of CLCN1, SCN4A, KCNJ2, CACNA1S genes in patients with muscle channelopathies. 178
Painful sensory neuropathy and dysimmunity: is there a relation? 178
Long-term effect of Rituximab in antii-MAG polyneuropathy 171
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 170
Long term efficacy of Rituximab in anti-MAG polyneuropathy 163
Autoimmunity in painful sensory neuropathy 162
Multifocal motor neuropathy with an unusual clinical presentation 161
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 161
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 161
A case-control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain-Barré syndrome in Western Lombardia 160
Guillain-Barré syndrome : an Italian multicentre case-control study 157
Polyneuropathy in POEMS syndrome : role of angiogenic factors in the pathogenesis 156
Anti-sulfatide IgM antibodies in peripheral neuropathy 154
Anti-GM1 IgM antibodies in motor neuron disease and neuropathy 150
Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins 149
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation 147
New abnormalities in the CSF of vitamin B12-deficient patients 145
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy 145
Antecedent infections in Guillain Barré syndrome (GBS) in northern Italy: a clinical and serological case-control study 145
Abnormal expression of cyclin-dependent kinase in an atypical case of desminopathy 144
VEGF and BFGF modulation are not involved in thalidomide-induced neuropathy 141
Gangliosides. Their role in clinical neurology 141
Multifocal motor neuropathy: clinical and immunological features and response to IVIg therapy in patients with definite, probable or no overt conduction block 141
Vascular Endotelial growth factor serum concentration and diabethic neuropathy 140
Detection of anti-glycolipid antibodies by a Dot-Blot analysis: could it be a valid alternative? 139
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia 139
Anti-campylobacter jejuni lipopolysaccharide reactivity in multifocal motor neuropathy 139
Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies 137
MONOCLONAL IGMK IN A PATIENT WITH MOTOR NEURON DISEASE BINDS TO GM1, GD1B, AND TO HIGH MOLECULAR CENTRAL NERVOUS SYSTEM-SPECIFIC GLYCOCONJUGATES 134
A case control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in GBS: correlation with antecedent event and with clinical features 133
POEMS sindrome: role of two angiogenic factors, VEGF and EPO 132
Is campylobacter jejuni enteritis a risk factor for Guillain Barré sindrome in Italy? A case control study by western blot in northern Italy 131
Different types of neuropathic pain in a large cohort of Italian patients with peripheral nervous system diseases 129
Predictors of response to Rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M 128
Are there immunologically treatable motor neuron diseases? 128
Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component 128
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor neuropathy (MMN) 128
Anti-GD1a ganglioside antibodies in peripheral motor syndromes 127
Treatment of multifocal motor neuropathy 127
Anti-ganglioside and anti-Campylobacter Jejuni (CJ) antibodies in Guillain-Barré syndrome (GBS): regional and temporal variability in Italian patients 127
A case Control study of anti-ganglioside and anti-Campylobacter jejuni antibnodies in Guillain Barré syndrome in western Lombardia 127
Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies 126
Clinical relevance of anti-GM1 IgM antibodies 126
The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the N-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide 126
Multifocal motor neuropathy and campylobacter jejuni reactivity 126
Serum antibodies to campylobacter jejuni in multifocal motor neuropathy 125
IgM reactivity with a human neuroblastoma cell line in patients with peripheral neurological disorders 125
Novel missense GARS gene mutation in an Italian family with hereditary distal motor neuropathy 124
Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy 124
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 124
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor nuropathy (MMN) 124
Long-term effect of IVIg in multifocal motor neuropathy 123
Predictive value of anti-GM1 IgM and IgG antibodies for dysimmune neuropathies 123
An atypical case of desminopathy with abnormal expression of cyclin-dependent kinase 123
Long-term effect of intravenous immunoglobulin therapy (IVIg) in multifocal motor neuropathy (MMN) 121
Anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain Barré syndrome: A case control study 121
Clinical and immunological study in neuropathy associated with IgG MGUS 120
Neurological complication in Celiac Disease: could have an autoimmune origin? 119
Pain: a frequent and often overlooked presenting symptom in Guillain Barré syndrome 119
Anti-GD1a antibodies in motor neuropathies 117
Anti-GM1 antibodies in multifocal motor neuropathy : effect of intravenous immunoglobulin therapy 117
Deterioration of multifocal motor neuropathy after plasma exchange 116
Long-term efficacy of Rituximab in anti-MAG polyneuropathy 116
IgM reactivitry with a human neuroblsatoma cell line in patients with peripheral neurological disorders 116
Atypical anti-neuronal reactivity in neurological disorders : could have another role besides being paraneoplastic? 115
Thalidomide-induced neuropathy is a distal axonopathy not due to VEGF inhibition 115
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 115
Proximal myotonic myopathy (PROMM) syndrome without CTG expansion: a new case 114
Residual disability and psychosocial status after Guillain Barré syndrome: a 3 to 5 year follow-up study 113
Antigen specificity of the M-protein in 77 patients with neuropathy and IgM monoclonal gammopathy 112
Guillain Barre' Syndrome associated with high titers of anti-GM1 antibodies 111
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy 111
Anti-GM1 IgG antibodies in Guillain Barre' Syndrome 111
Risk factors for Guillain Barré sindrome (GBS) in northern Italy: analysis of anamnestic antecedent events and serological evidence of infections 110
Clinical and immunological features and response to IVIg in patients with clinically typical multifocal motor neuropathy but no overt conduction block 109
Long –term efficay of Rituximab in anti-MAG plyneuropathy 109
Totale 21.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 0 0 303
2021/20222.326 191 115 141 169 185 278 131 118 260 180 192 366
2022/20232.700 323 219 224 287 300 457 93 150 252 110 141 144
2023/20241.853 112 145 124 121 314 94 129 140 83 178 196 217
2024/20253.647 175 327 147 343 422 170 212 373 261 326 255 636
2025/20265.974 475 224 524 463 636 522 762 441 700 505 466 256
Totale 27.469